MedTrace Logo

AgION Catheter for Preventing Catheter-Related Bloodstream Infections

NCT01564615 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2012-03-28

No results posted yet for this study

Summary

The investigators assessed if use of AgION-impregnated umbilical catheters can decrease the occurrence of catheter-related bloodstream infections (CRBSI) in preterm infants.

Conditions

  • Catheter-Related Infections

Interventions

DEVICE

Umbilical catheterization (AgION )

Infants received a AgION impregnated catheter (4.0-5.0 F Lifecath PICC ExpertTM, Vygon, Ecouen, France).

DEVICE

Umbilical catheterization (ArgyleTM)

Infants received a polyurethane non-impregnated catheter (3.5-5.0 F ArgyleTM, Kendall, Tullamore, Iceland)

Sponsors & Collaborators

  • University of Florence

    lead OTHER

Principal Investigators

  • Carlo Dani, MD · Department of Surgical and Medical Critical Care, Section of Neonatology, University of Florence

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01564615 on ClinicalTrials.gov